Bayer has secured another Roundup trial win after a Philadelphia jury determined that subsidiary Monsanto’s weed killer is defective but did not cause plaintiff Ryan Young’s non-Hodgkin lymphoma. This is the second victory for Bayer this month after a Missouri appeals court also upheld a previous win for the company. In that trial, plaintiff Stacey Moore had appealed in part based on the exclusion of his expert’s testimony in the original trial, but the appeals court affirmed that the expert was not qualified to discuss Roundup’s potential ties to cancer. Bayer has now seen several wins in recent months as it continues to push for Roundup litigation to make its way to the Supreme Court.

In a potential blow to plaintiffs, the 3rd U.S. Circuit Court of Appeals in Philadelphia has ruled in Monsanto and Bayer’s favor in Schaffner v. Monsanto. The court determined in a unanimous ruling that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state law that the Schaffners claimed Monsanto violated by not including cancer warnings on labels. This creates a circuit split with previous rulings, and Bayer is pushing for the issue to be determined in front of the Supreme Court.

Judge Ann Butchart of the Philadelphia Court of Common Pleas upheld the Monsanto's only winning trial verdict in that court. According to our research, this ruling could affect cases going forward because it allowed Monsanto to show evidence from the EPA that does not link the product to cancer but didn't allow plaintiffs to present evidence from the International Agency for Research on Cancer that does link the product to cancer. Plaintiffs are appealing this ruling.

This month, Bayer also began lobbying Congress to add language to an upcoming farm bill that will protect it from lawsuits that allege Roundup causes cancer. An Oregon appeals court also overturned a previous Bayer win in a Roundup trial this month. The decision was based on the determination that the trial court committed an error by excluding certain testimony regarding EPA regulation. In research news, French scientists published a study in Ecotoxicology and Environmental Safety that suggests that glyphosate has a negative impact on human reproductive health by contributing to infertility.

A state court judge slashed a $2.25 billion verdict for a Pennsylvania man to $400 million dollars. The jury had originally awarded him $2 billion in punitive damages. Bayer said it would continue to appeal the decision.

Meanwhile, Bayer was reportedly heavily investing in lobbying efforts to influence Congress in favor of passing a law that would restrict Roundup-related lawsuits. Part of this campaign involved a clause in the farm bill, which Bayer helped draft, aiming to limit plaintiffs' claims of being uninformed about the herbicide's health risks.

Plaintiffs continued to file new lawsuits in the MDL. The latest New York plaintiff used Roundup for about 10 years before being diagnosed with non-Hodgkin lymphoma in 2023.

A Missouri court reduced the $1.56 billion verdict from November 2023 to $611 million. This was based on a U.S. Supreme Court decision limiting punitive damages to no more than 9 times the actual damages.

Plaintiffs’ attorneys considered consolidating cases in a New Jersey multicounty litigation. Meanwhile, the plaintiff in Kline v. Monsanto was appealing the Philadelphia jury’s defense verdict.

The 11th U.S. Circuit Court of Appeals rejected Bayer's argument on federal labeling of pesticides trumping state requirements that they come with a cancer warning. This complicates Bayer's legal strategy to deal with lawsuits claiming Roundup cancer links.

A Pennsylvania jury awarded John McKivison a $2.25 billion verdict after a trial in which he claimed Roundup caused his non-Hodgkin lymphoma. His lawsuit claimed he'd used the weedkiller around his property for 20 years.

A jury ordered Bayer to pay $3.5 million to a plaintiff who claimed Roundup caused her to develop cancer.

A jury in Missouri awarded $1.56 billion to four plaintiffs who claimed Roundup caused them or their spouse to develop non-Hodgkin lymphoma. Out of about 165,000 lawsuits, 113,000 had been resolved, according to Bayer.

A jury in San Diego jury awarded $332 million to a cancer patient after finding Monsanto didn’t adequately warn of the cancer risks of Roundup.

Bayer settled claims for misleading consumers about the environmental effects of Roundup.

Monsanto won the latest trial in St. Louis, Missouri against plaintiff Sharlean Gordon. This was the company’s seventh consecutive win.

Monsanto won its fifth consecutive trial in St. Louis, Missouri.

San Francisco Judge Vince Chhabria denied Bayer’s Roundup class action lawsuit offer to settle future Roundup cancer claims for $2 billion.

Bayer offered $10.9 billion to settle about 100,000 Roundup weed killer lawsuit claims.

A California state jury awarded $2 billion to a Roundup plaintiff.

A California state jury awarded $80 million to a Roundup plaintiff.

A California state jury awarded $289 million to a Roundup plaintiff.